IGF1 and obesity due to melanocortin 4 receptor deficiency: Nowadays, increasing evidences suggest that a lower IGF-1 level is associated with obesity [4], insulin resistance [5], metabolic syndrome [6, 7], impaired glucose tolerance [8], nonalcoholic fatty liver disease (NAFLD) [9] and cardiovascular disease [10].